Here are a few recent findings that inspired this article: Tirzepatide and Joint Pain Relief A 2024 population study found that people taking Tirzepatide had a lower risk of developing joint painespecially in the knees, hips, and lower backand used fewer anti-inflammatory or opioid medications than those who werent on the treatment
It works differently from GLP-1 medications and produces less weight loss (around 3% over a year)
She also shared that only four countries offer insurance coverage for obesity treatment: Brazil, Canada, Chile and the U.S
Hydration Many side effects, including headaches, dizziness, constipation, and fatigue, worsen with dehydration
If you experience significant nausea, switching to lower intensity activities may help